CAS: 3248-91-7; New Fuchsin

该化合物是属于三苯甲烷染色类的合成染料,其特征是其充满活力的红红色,其特点是其复杂的分子结构包括多芳香环,该色素在水和酒精中溶解,在各种应用中,包括用于污渍目的的生理学和微生物学中,它有用.新芬辛对生物组织表现出强烈的亲近性,允许在显微镜下对细胞成分进行可视化.此外,它还在纺织业中应用染色布料.染色之所以有其稳定性和耐性,是因为对光和热可能敏感.安全考虑很重要,因为新芬辛可能是一种潜在的刺激剂,并被归类为可能的致癌物质.应当遵循适当的处理和处置程序,以减轻与接触有关的任何健康风险.

结构式图片

相似化合物

569-61-9 569-64-2 548-62-9

欧盟法规

欧盟化妆品法规附录三-限用物质清单REACH注册ECHA物质ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2005080260-A1
    优先权日:2003-04-22
    标 题 :Preparation of prodrugs for selective drug delivery
    发明人:MILLS RANDELL L; WU GUO-ZHANG
    摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

    专利号:US-2023097824-A1
    优先权日:2020-05-08
    标 题:Semi-synthesis and use of racemic hematoxylin
    发明人:DURRANT EDWARD E; HEINDL DIETER; HUBER FLORIAN MAURITIUS ERASUMU; KLEIN ERIC; KOSMEDER II JEROME W; VOSS EDGAR
    权利人:VENTANA MED SYST INC; ROCHE DIAGNOSTICS OPERATIONS INC
    摘要:A racemic hematoxylin formulation is disclosed that includes one or both of a stabilizer compound and an antioxidant. The disclosed composition exhibits sufficient stability to be utilized in an automated staining process. Methods of using and making the stabilized composition also are disclosed.

    专利号:US-10772990-B2
    优先权日:2014-04-01
    标题 :Tissue filler compositions and methods of use
    发明人:NIKOLIS ANDREAS; HERBERT LISE
    权利人:KLOX TECH INC
    摘要:The present disclosure relates to methods for stimulating collagen synthesis, cosmetic enhancement of soft tissue and/or inhibiting or treating scarring comprising administering a composition to an area to be treated within a soft tissue, wherein the composition comprises a tissue filler medium and a fluorophore; and illuminating the area with light having a wavelength which can be absorbed by the fluorophore.

    专利号:US-2003186237-A1
    优先权日:2001-02-14
    标题:Methods and compositions of amplifying RNA
    发明人:GINSBERG STEPHEN D; CHE SHAOLI
    权利人:BAYLOR COLLEGE MEDICINE
    摘要:The present invention pertains to a method that will increase the efficiency of second strand cDNA synthesis through a mechanism of “terminal continuationâ€? before further RNA amplification by RNA transcription using, for example, a bacteriophage promoter. In a specific embodiment, a transcription promoter is attached to the 5′ region of cDNA through the same mechanism of “terminal continuationâ€?. Genetic signals are subsequently amplified in a linear manner through RNA transcription. In specific embodiments, the orientation of the transcribed RNA is either sense or antisense, depending on the desired downstream application. In other embodiments, the present invention pertains to methods for extraction and amplification of RNA, particularly mRNA, from histologically stained tissues and cells.

    专利号:WO-2021224361-A2
    优先权日:2020-05-08
    标题 :Semi-synthesis and use of racemic hematoxylin

    专利号:CN-115612114-A
    优先权日:2021-07-14
    标 题:Method and application of copolymer film and its enzymatic self-assembly synthesis

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    参考文献:10.1007/bf00123399
    摘要:Brandt B, Griwatz C, Heidl S, Assmann G, Zänker KS. Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR. Clinical & Experimental Metastasis. 1996 Sep;14(4):399–408. doi: 10.1007/bf00123399.
    参考文献:10.1007/s00428-001-0554-0
    摘要:Bamberger AM, Kappes H, Methner C, Rieck G, Brümmer J, Wagener C, Löning T, Milde-Langosch K. Expression of the adhesion molecule CEACAM1 (CD66a, BGP, C-CAM) in breast cancer is associated with the expression of the tumor-suppressor genes Rb, Rb2, and p27. Virchows Arch. 2002 Feb;440(2):139–44. doi: 10.1007/s00428-001-0554-0.
    参考文献:10.1007/bf00190562
    摘要:Mori S. Demonstration of isolated follicular dendritic cells in lymphatic vessels around human immunodeficiency virus-infected lymph nodes. Virchows Arch. 1994;424(4):397–401. doi: 10.1007/bf00190562.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知